Join to View Full Profile
4901 Forest Park AveFl 6Saint Louis, MO 63108
Phone+1 314-362-3937
Fax+1 314-362-3725
Dr. Apte is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Rajendra Apte is an ophthalmologist in Saint Louis, MO. He is the Paul A. Cibis Distinguished Professor and Vice Chair of Innovation and Translation at Washington University in St. Louis School of Medicine and Barnes Hospital. He received his medical degree from University of Bombay. He did his graduate thesis and residency at Parkland Hospital/UT Southwestern and his vitreoretinal fellowship at Johns Hopkins Wilmer Eye Institute and has been in practice 20 years. He specializes in retinal disease and is experienced in diabetic retinopathy, macular degeneration, retina surgery, vitreoretinal disease, and electrophysiology of vision. He has more than 150 publications and over 5000 citations. He is world renowned as a surgeon, innovator, entrepreneur and scientist.
Education & Training
LTMMCClass of 1992
Certifications & Licensure
IL State Medical License 2000 - 2026
MO State Medical License 2003 - 2026
MD State Medical License 2001 - 2004
American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- Therapeutic interventions for chronic central serous chorioretinopathy: a comprehensive assessment of systematic reviews.Henok Getahun, Rajendra S Apte
International Journal of Retina and Vitreous. 2025-03-23 - Energetic diversity in retinal ganglion cells is modulated by neuronal activity and correlates with resilience to degeneration.Zelun Wang, Christopher Zhao, Shelly Xu, Sean McCracken, Rajendra S Apte
Research Square. 2025-03-12 - The Landscape of Vascular Endothelial Growth Factor Inhibition in Retinal Diseases.Joseph B Lin, Rajendra S Apte
Investigative Ophthalmology & Visual Science. 2025-01-02
Press Mentions
MetroBiotech Kicks off Human Trial of New NAD BoosterApril 24th, 2025- Repurposed Drug May Help Stabilize Vision in Rare DiseaseJune 17th, 2024
- No Visual Acuity Benefit with Early Anti-VEGF for Diabetic RetinopathyFebruary 7th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
